During visual fixation, the eyes produce small involuntary movements, called fixational eye movements (FEMs), which are conventionally separated into saccadic-like jumps (more generally referred to as saccadic intrusions, fixational saccades, or microsaccades), drift, and tremor (Steinman, Haddad, Skavenski, & Wyman,
1973; Abadi, Clement, & Gowen,
2003; Collewijn & Kowler,
2008). During the last decades FEM research has gained a renewed interest due to the possible involvement in perception and attention (Engbert,
2006; Hafed, Chen, & Tian,
2015) and to neurophysiological evidence showing that neural activity is sensitive to different types of FEMs (Martinez-Conde, Macknik, & Hubel,
2000; Kagan, Gur, & Snodderly,
2008). While little functional significance has been attributed to tremor, multiple roles for drift and fixational saccades were suggested. These include error correction (Cornsweet,
1956; Poletti & Rucci,
2010), gaze relocation in high-acuity tasks (Ko, Poletti, & Rucci,
2010; Tian, Yoshida, & Hafed,
2016), enhancement of high-frequency content in input images (Kuang, Poletti, Victor, & Rucci,
2012), and prevention of image fading (Ditchburn, Fender, & Mayne,
1959; Martinez-Conde, Macknik, Troncoso, & Dyar,
2006, but see Collewijn & Kowler,
2008; Poletti & Rucci,
2010). In addition, eye movements, including microsaccades, have been linked with postural sway (Hunter & Hoffman,
2001; Jahn,
2002; Rolfs, Engbert, & Kliegl,
2004). In a more cognitive domain, timing of microsaccades has been associated with shifts in covert attention (Hafed & Clark,
2002; Engbert & Kliegl,
2003; Yuval-Greenberg, Merriam, & Heeger,
2014) and was shown to correlate with the task-induced cognitive load (Bonneh, Adini, Fried, & Arieli,
2011). Given these diverse functional roles of FEMs, eye movement analysis is often used as a diagnostic tool in clinical and aging research (Leigh & Zee,
2015). In particular, changes in eye movement properties with respect to age-matched controls have been characterized in patients with age-related macular degeneration (Moller & Bek,
1998; Macedo, Crossland, & Rubin,
2011), glaucoma (Crabb, Smith, & Zhu,
2014), Parkinsonian disorders (Otero-Millan et al.,
2011), and Alzheimer disease (Parkinson & Maxner,
2005; Kapoula et al.,
2014).